CDN Connection Issue

It appears that your current network does not allow connection to the CDN (Content Delivery Network) required for this service to function properly.

To resolve this issue, please try the following actions :

• Contact your network administrator : Inform them of this restriction so they can adjust the network settings accordingly.

• Use another network : Try connecting from a different network, such as another Wi-Fi network or a mobile connection.

We apologize for the inconvenience and thank you for your understanding.

Homepage / Professor Palak Trivedi: Patient Identification in PBC

Professor Palak Trivedi: Patient Identification in PBC

Clinical Experience from Birmingham: Identifying Patients suitable

for treatment with OCALIVA^®▼(obeticholic acid)

In this recording, Prof. Palak Trivedi shares his clinical experience from Birmingham on identifying adults with Primary Biliary Cholangitis (PBC) who may warrant consideration for treatment with OCALIVA^®.
Content includes patient identification, treatment considerations and monitoring in clinical practice.

For prescribing information and adverse event reporting, click here

Search criterias

2026-10-26

6 min

Adverse events should be reported. Reporting forms and information for the UK can be found at https://yellowcard.mhra.gov.uk/ and also report using the Yellow Card app. The app is available to download from the Apple App Store, or Google Play Store and you can use your Yellow Card website account details on the app to report. Adverse events should also be reported to ADVANZ PHARMA Medical Information via telephone on +44 (0) 208 588 9131 or via e-mail at medicalinformation@advanzpharma.com

Country Selector

Professor Palak Trivedi: Patient Identification in PBC

Clinical Experience from Birmingham: Identifying Patients suitable

for treatment with OCALIVA®▼(obeticholic acid)

Search criterias

#{title}

for treatment with OCALIVA^®▼(obeticholic acid)